
What We're Reading: Labs Struggle With Testing Demand; Efficacy of COVID-19 Antibodies; Opioid Overdoses Amid Pandemic
Labs nationwide are struggling to meet the processing demands of surging coronavirus disease 2019 (COVID-19) tests, causing long delays; levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, were found to drop dramatically across the first 3 months of infection; suspected opioid-related overdoses have more than doubled in Wisconsin amid the pandemic.
US Labs Struggling Amid Testing Demand
Reported by
COVID-19 Antibodies Found to Decay Quickly After Mild Illness
In findings from a research letter published this week in the New England Journal of Medicine, levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, dropped dramatically across the first 3 months of infection. Reported by
Opioid Overdoses More Than Double in Wisconsin Amid Pandemic
Amid the COVID-19 pandemic, there have been more than double as many suspected opioid-related
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.